Biochemical Reagent
-
BA2307 BurfiralimabSummary: Burfiralimab (hzVSF-v13) is a monoclonal antibody directed against waveform proteins expressed on the surface of virus-infected cells with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. - BA2308 Z-Arg-Leu-Arg-Gly-Gly-AMCSummary: A peptide substrate for PL.
- BA2309 PLpro-IN-1Summary: PLpro-IN-1 is an inhibitor (8.7 μM).
- BA2310 NGI-1Summary: NGI-1 (ML414) is a potent inhibitor of oligosaccharyltransferases that directly targets and blocks the function of the OST catalytic subunits STT3A and STT3B.
- BA2311 4E2RCatSummary: 4E2RCat is an inhibitor of the interaction.
- BA2313 SID-852843Summary: SID-852843 is a protease inhibitor.
- BA2314 Flaviviruses-IN-3Summary: Flaviviruses-IN-3 is a potent inhibitor.
- BA2315 PolatuzumabSummary: Polatuzumab is a monoclonal antibody with a chemotherapeutically active molecule.
- BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans.
- BA2317 IzeltabartSummary: Izeltabart is a high affinity humanized antibody that targets.